anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Equillium · pitchdeck

Equillium | Investor Presentation Deck | 39 slides

39 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Equillium | Investor Presentation Deck | 39 slides

Equillium · 2023-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 11 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 3 slides 100% 3/3 slides 100% 3/3 slides · 15 hits
— 0/3 slides
33.3% 1/3 slides 66.7% 2/3 slides 100% 3/3 slides
— 0/3 slides
Solution 4 slides 100% 4/4 slides 100% 4/4 slides · 16 hits
— 0/4 slides
25% 1/4 slides
— 0/4 slides
100% 4/4 slides
— 0/4 slides
Market Size 2 slides 100% 2/2 slides 100% 2/2 slides · 14 hits
— 0/2 slides
100% 2/2 slides 50% 1/2 slides 100% 2/2 slides
— 0/2 slides
Team 2 slides 100% 2/2 slides 100% 2/2 slides · 17 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides
— 0/2 slides

Slide inventory

39
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a hub-and-spoke diagram to centralize the company brand around key investment pillars.summarize
Open slide detail
04
The slide uses a Gantt-style visualization for clinical trial stages.plan_implementation
Open slide detail
05
This is a section divider or introductory slide for the product solution.present_solution
Open slide detailBeat · Solution
06
Includes footnote regarding currency exchange rate for the option exercise payment.show_traction
Open slide detailBeat · Solution
07
plan_implementation
Open slide detailBeat · Solution
08
transition
Open slide detailBeat · Solution
09
Includes a diagram illustrating cytokine-receptor binding and downstream signaling.establish_context
Open slide detailBeat · Problem
10
The slide uses a visual comparison to frame the problem of 'too narrow' vs 'too broad' inhibition.frame_problem
Open slide detailBeat · Problem
11
The diagram uses a hub-and-spoke model to show how various scientific disciplines feed into the central 'Drug Products' core.present_solution
Open slide detailBeat · Problem
12
The slide highlights the structural commonality of the γC receptor across multiple cytokines, positioning it as a therapeutic target.present_solution
Open slide detail
13
The slide illustrates a structural biology approach to drug design, focusing on helix-receptor interactions and sequence engineering.present_solution
Open slide detail
14
The slide uses a combination of biological process diagrams and a bar chart to demonstrate selective inhibition.present_solution
Open slide detail
15
The slide uses a visual comparison framework to illustrate the mechanism of action and therapeutic benefits.present_solution
Open slide detail
16
transition
Open slide detail
17
The slide uses a structured layout to compare four distinct market segments (Cutaneous T cell Lymphoma, Alopecia Areata, Vitiligo, Atopic Dermatitis) with specisize_opportunity
Open slide detailBeat · Market Size
18
The slide uses a four-column structure to explain the target, the molecule type, preclinical results, and clinical results.present_solution
Open slide detailBeat · Market Size
19
Western blot data visualization comparing pathway activation (pSTAT, pERK, pPI3K) under different treatment conditions.compare_peers
Open slide detail
20
Includes comparative data against Mogamulizumab (MAVORIC trial) and visual evidence of skin improvement.show_traction
Open slide detail
21
show_traction
Open slide detail
22
The slide uses a circular process diagram to show the feedback loop of immune cell activation and hair follicle damage.present_solution
Open slide detail
23
Includes photographic evidence of hair regrowth over 21 days and a bar chart showing fold reduction of NKG2D marker.show_traction
Open slide detail
24
The slide compares two different drugs (baricitinib and deuruxolitinib) using their respective clinical trial data (BRAVE AA1 and THRIVE AA1).compare_peers
Open slide detail
25
Includes a blackbox warning text block as a competitive/safety barrier context.frame_problem
Open slide detailLoop · Cost Of Inaction
26
The slide outlines a clinical trial methodology and the strategic positioning of the drug candidate.present_framework
Open slide detailLoop · Cost Of Inaction
27
transition
Open slide detail
28
Uses a contrast-based framing (750k patients vs 0 drugs) to establish market opportunity.frame_problem
Open slide detail
29
The slide uses a four-column structure to explain the biological rationale, molecular nature, mechanism of action, and clinical status.present_solution
Open slide detail
30
Includes a heatmap showing gene expression profiles under different cytokine conditions.frame_problem
Open slide detail
31
The slide uses a circular process diagram to show the mechanism of action and a bar chart to show efficacy.present_solution
Open slide detail
32
The slide uses a process-like flow to highlight the specific mechanism of action (IL-15/IL-21) compared to other approaches.size_opportunity
Open slide detailLoop · Why Now
33
The slide outlines a sequential clinical trial process.plan_implementation
Open slide detailLoop · Why Now
34
transition
Open slide detail
35
The slide combines individual team member bios with a collective logo grid of past affiliations.other
Open slide detailBeat · Team
36
The slide uses a Gantt-style timeline to show the duration of IP protection for various therapeutic assets.other
Open slide detailBeat · Team
37
Includes a disclaimer regarding the Form 10-Q and a footnote about debt facility prepayment.summarize
Open slide detail
38
The slide uses a table-like structure to present clinical trial milestones and financial runway.plan_implementation
Open slide detail
39
front_matter
Open slide detail